Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Chlamydia Infections | 13 | 2015 | 79 | 2.970 |
Why?
|
| Mass Screening | 10 | 2015 | 695 | 1.640 |
Why?
|
| Chlamydia trachomatis | 8 | 2015 | 60 | 1.530 |
Why?
|
| Health Knowledge, Attitudes, Practice | 7 | 2015 | 767 | 1.390 |
Why?
|
| Comprehension | 3 | 2015 | 138 | 1.070 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2017 | 494 | 1.000 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 70 | 0.790 |
Why?
|
| Uterine Cervical Neoplasms | 3 | 2017 | 151 | 0.730 |
Why?
|
| Internet | 3 | 2015 | 466 | 0.700 |
Why?
|
| Sexually Transmitted Diseases | 4 | 2015 | 95 | 0.700 |
Why?
|
| Adolescent | 21 | 2017 | 6283 | 0.680 |
Why?
|
| Specimen Handling | 2 | 2015 | 61 | 0.650 |
Why?
|
| Ambulatory Care Facilities | 4 | 2015 | 105 | 0.620 |
Why?
|
| Vaginal Smears | 6 | 2014 | 59 | 0.600 |
Why?
|
| Health Education | 2 | 2015 | 188 | 0.590 |
Why?
|
| Decision Trees | 3 | 2015 | 48 | 0.580 |
Why?
|
| Referral and Consultation | 2 | 2015 | 437 | 0.570 |
Why?
|
| HIV Infections | 3 | 2015 | 956 | 0.560 |
Why?
|
| Papillomavirus Infections | 2 | 2017 | 133 | 0.530 |
Why?
|
| Professional-Patient Relations | 1 | 2017 | 126 | 0.480 |
Why?
|
| Pelvic Inflammatory Disease | 3 | 2008 | 25 | 0.470 |
Why?
|
| Health Communication | 1 | 2015 | 33 | 0.450 |
Why?
|
| Electronic Prescribing | 1 | 2015 | 11 | 0.440 |
Why?
|
| AIDS Vaccines | 1 | 2015 | 73 | 0.430 |
Why?
|
| Informed Consent | 1 | 2015 | 141 | 0.420 |
Why?
|
| Sensitivity and Specificity | 8 | 2011 | 1160 | 0.380 |
Why?
|
| Lymphogranuloma Venereum | 1 | 2012 | 3 | 0.380 |
Why?
|
| Parents | 1 | 2017 | 412 | 0.380 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 45 | 0.370 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 52 | 0.370 |
Why?
|
| Cost-Benefit Analysis | 6 | 2015 | 315 | 0.360 |
Why?
|
| Clinical Trials as Topic | 2 | 2015 | 460 | 0.360 |
Why?
|
| Urine | 3 | 2009 | 45 | 0.340 |
Why?
|
| Point-of-Care Systems | 1 | 2012 | 127 | 0.330 |
Why?
|
| Female | 22 | 2017 | 33873 | 0.330 |
Why?
|
| Trichomonas Vaginitis | 2 | 1999 | 7 | 0.300 |
Why?
|
| Health Maintenance Organizations | 1 | 2009 | 61 | 0.300 |
Why?
|
| Counseling | 1 | 2011 | 374 | 0.280 |
Why?
|
| Adult | 15 | 2015 | 17279 | 0.270 |
Why?
|
| Physician-Patient Relations | 1 | 2011 | 427 | 0.270 |
Why?
|
| Humans | 25 | 2017 | 64914 | 0.260 |
Why?
|
| Qualitative Research | 1 | 2011 | 745 | 0.250 |
Why?
|
| Surveys and Questionnaires | 5 | 2015 | 2757 | 0.250 |
Why?
|
| Adolescent Health Services | 2 | 2004 | 19 | 0.240 |
Why?
|
| Antisepsis | 1 | 2006 | 7 | 0.240 |
Why?
|
| Health Behavior | 2 | 2007 | 482 | 0.240 |
Why?
|
| Perineum | 1 | 2006 | 19 | 0.240 |
Why?
|
| Central Nervous System Stimulants | 1 | 2006 | 66 | 0.230 |
Why?
|
| Vaccination | 3 | 2015 | 374 | 0.230 |
Why?
|
| Carboxylic Ester Hydrolases | 1 | 2005 | 11 | 0.230 |
Why?
|
| Patient Selection | 1 | 2008 | 483 | 0.220 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 2005 | 25 | 0.220 |
Why?
|
| Urinary Tract Infections | 1 | 2006 | 97 | 0.220 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2004 | 29 | 0.210 |
Why?
|
| Papanicolaou Test | 1 | 2004 | 46 | 0.210 |
Why?
|
| Predictive Value of Tests | 4 | 2011 | 1103 | 0.210 |
Why?
|
| Students | 1 | 2006 | 225 | 0.210 |
Why?
|
| Terminology as Topic | 1 | 2004 | 145 | 0.200 |
Why?
|
| Trichomonas vaginalis | 2 | 1999 | 9 | 0.190 |
Why?
|
| Urinalysis | 3 | 2008 | 37 | 0.190 |
Why?
|
| Male | 11 | 2017 | 30904 | 0.190 |
Why?
|
| Decision Support Techniques | 1 | 2004 | 193 | 0.180 |
Why?
|
| Prisoners | 1 | 2004 | 179 | 0.170 |
Why?
|
| Self Administration | 2 | 2011 | 49 | 0.160 |
Why?
|
| Prevalence | 3 | 2011 | 1438 | 0.150 |
Why?
|
| Young Adult | 3 | 2015 | 4783 | 0.150 |
Why?
|
| Candidiasis, Vulvovaginal | 1 | 1998 | 8 | 0.140 |
Why?
|
| Cohort Studies | 3 | 2011 | 2609 | 0.140 |
Why?
|
| Vaginosis, Bacterial | 1 | 1998 | 15 | 0.140 |
Why?
|
| Adolescent Behavior | 3 | 2005 | 194 | 0.140 |
Why?
|
| Substance-Related Disorders | 1 | 2006 | 750 | 0.140 |
Why?
|
| DNA, Bacterial | 2 | 2011 | 260 | 0.140 |
Why?
|
| Age Factors | 2 | 2013 | 1579 | 0.140 |
Why?
|
| Focus Groups | 2 | 2011 | 319 | 0.120 |
Why?
|
| Audiovisual Aids | 1 | 2015 | 11 | 0.120 |
Why?
|
| Informed Consent By Minors | 1 | 2015 | 4 | 0.110 |
Why?
|
| Reagent Kits, Diagnostic | 1 | 2015 | 25 | 0.110 |
Why?
|
| Public Health Surveillance | 1 | 2014 | 27 | 0.110 |
Why?
|
| Program Development | 1 | 2015 | 208 | 0.100 |
Why?
|
| Child | 3 | 2017 | 4603 | 0.100 |
Why?
|
| United States | 3 | 2012 | 8065 | 0.100 |
Why?
|
| Multivariate Analysis | 2 | 2006 | 928 | 0.100 |
Why?
|
| Program Evaluation | 1 | 2015 | 488 | 0.090 |
Why?
|
| Attitude to Health | 2 | 2006 | 296 | 0.090 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2013 | 130 | 0.090 |
Why?
|
| Costs and Cost Analysis | 1 | 2012 | 105 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 625 | 0.090 |
Why?
|
| Pilot Projects | 1 | 2015 | 1009 | 0.090 |
Why?
|
| Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 | 1 | 2011 | 7 | 0.090 |
Why?
|
| Health Surveys | 1 | 2013 | 317 | 0.090 |
Why?
|
| Gonorrhea | 2 | 2004 | 162 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2011 | 201 | 0.080 |
Why?
|
| Logistic Models | 1 | 2013 | 1268 | 0.080 |
Why?
|
| Public Health | 1 | 2011 | 186 | 0.080 |
Why?
|
| Confidentiality | 1 | 2009 | 58 | 0.070 |
Why?
|
| Sexually Transmitted Diseases, Bacterial | 1 | 2008 | 2 | 0.070 |
Why?
|
| Interviews as Topic | 1 | 2011 | 529 | 0.070 |
Why?
|
| Vagina | 2 | 1999 | 87 | 0.070 |
Why?
|
| Maryland | 1 | 2008 | 36 | 0.070 |
Why?
|
| Motivation | 1 | 2009 | 294 | 0.060 |
Why?
|
| Employment | 1 | 2008 | 132 | 0.060 |
Why?
|
| Pediatrics | 1 | 2009 | 265 | 0.060 |
Why?
|
| Patient Care Team | 1 | 2009 | 335 | 0.060 |
Why?
|
| Bacteriuria | 1 | 2006 | 16 | 0.060 |
Why?
|
| Colony Count, Microbial | 1 | 2006 | 59 | 0.060 |
Why?
|
| Odds Ratio | 1 | 2007 | 755 | 0.060 |
Why?
|
| New England | 1 | 2006 | 269 | 0.060 |
Why?
|
| Peer Group | 1 | 2006 | 113 | 0.060 |
Why?
|
| Universities | 1 | 2006 | 168 | 0.060 |
Why?
|
| Reference Values | 1 | 2005 | 326 | 0.050 |
Why?
|
| Sexual Behavior | 1 | 2005 | 191 | 0.050 |
Why?
|
| Medical Records | 1 | 2004 | 139 | 0.050 |
Why?
|
| Linear Models | 1 | 2004 | 406 | 0.050 |
Why?
|
| Population Surveillance | 1 | 2004 | 210 | 0.050 |
Why?
|
| Mass Media | 1 | 2003 | 33 | 0.050 |
Why?
|
| Dyspareunia | 1 | 2003 | 9 | 0.050 |
Why?
|
| Vaginitis | 1 | 2003 | 6 | 0.050 |
Why?
|
| Physical Examination | 1 | 2003 | 110 | 0.050 |
Why?
|
| Abdominal Pain | 1 | 2003 | 101 | 0.050 |
Why?
|
| Patient Compliance | 1 | 2004 | 364 | 0.050 |
Why?
|
| Cross-Sectional Studies | 1 | 2009 | 2694 | 0.040 |
Why?
|
| Patient Participation | 1 | 2003 | 231 | 0.040 |
Why?
|
| Risk Factors | 1 | 2011 | 5404 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2004 | 6824 | 0.040 |
Why?
|
| Chi-Square Distribution | 1 | 1999 | 414 | 0.040 |
Why?
|
| Surgical Instruments | 1 | 1998 | 44 | 0.040 |
Why?
|
| Massachusetts | 1 | 2004 | 2140 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2004 | 1133 | 0.030 |
Why?
|
| California | 1 | 2014 | 173 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 581 | 0.020 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 434 | 0.020 |
Why?
|
| Electronic Health Records | 1 | 2014 | 387 | 0.020 |
Why?
|
| Animals | 2 | 1999 | 21347 | 0.020 |
Why?
|
| Contact Tracing | 1 | 2008 | 17 | 0.020 |
Why?
|
| Models, Economic | 1 | 2008 | 42 | 0.020 |
Why?
|